Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
AI-powered sentiment analysis is giving real estate investors a major edge by scanning millions of online conversations to detect market shifts long before traditional data responds. From predicting neighborhood momentum to spotting declining tenant satisfaction, this technology captures real-time public emotion across office, retail, and multifamily sectors. As trends in sentiment become as important as demographics and NOI, professionals who understand these tools will stay ahead of the next market move.
Florida lawmakers are racing toward a high-stakes finish to the legislative session as a sweeping property tax overhaul triggers fierce debate. The House is pushing to eliminate most non-school property taxes on primary homes, while the Senate urges caution and Gov. Ron DeSantis floats even bigger changes. With Democrats warning of budget crises and only weeks left to strike a deal, the future of Florida’s tax structure—and its real estate market—hangs in the balance.
Florida homeowners are getting rare financial relief as the emergency insurance assessment—added after multiple insurers collapsed post‑Hurricane Ian—has been paid off two years early. The early payoff wipes out the charge of about $30 per household per year and delivers more than $650 million in statewide savings. With the insurance market stabilizing faster than expected, real estate and insurance professionals can expect a slightly more favorable environment for buyers and policyholders alike.
After years of pandemic‑driven disruption, rising vacancies, and interest‑rate volatility, confidence is finally returning to commercial real estate. Major analysts report that leasing activity is accelerating, investor appetite is rising, and high‑quality properties are leading the rebound. With investment volumes expected to jump and vacancies beginning to fall, 2026 is shaping up to be the long‑awaited turning point for the industry.
Sioux Falls enters 2026 with a commercial real estate market outperforming nearly every regional competitor. Fueled by strong fundamentals, major private investment, and confidence across all sectors, the city is positioned for what experts call “white‑hot economic activity.” From booming land sales and rising retail absorption to stabilizing office and industrial sectors, the metro’s momentum is undeniable—making it a prime environment for real estate professionals and investors looking for opportunity.
Florida lawmakers have advanced HB 767, a major insurance transparency bill that would create a statewide online rate database, boost consumer education, and prevent insurers from using land value to inflate premiums. The proposal promises clearer insurance data and stronger accountability—bringing much‑needed relief and insight to homeowners, real estate agents, mortgage professionals, and insurance producers across the state.
